We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Publication, Part of Prescribing for Diabetes
Prescribing for Diabetes in England - 2002-2008, An update
Official statistics- Publication Date:
- 11 Jun 2009
- Geographic Coverage:
- England
- Geographical Granularity:
- Country, Primary Care Trusts, Clinical Commissioning Groups, Primary Care Organisations
- Date Range:
- 01 Jan 2002 to 31 Dec 2008
Summary
Diabetes is a clinical area of high expenditure. This report presents national level trends in prescribing for diabetes in England with information that illustrates the increasing prevalence of diabetes and obesity in England.
It looks at information on primary and secondary care prescribing for diabetes from 2002 to 2008. The number of prescription items and Net Ingredient Cost (NIC) are used to analyse volume, expenditure and trends in the prescribing of insulin, oral anti-diabetic drugs and diagnostic and monitoring agents.
The report has been produced jointly by The NHS Information Centre and the Yorkshire and Humber Public Health Observatory (YHPHO), and is an update to an earlier report published in November 2007.
Highlights
- At the end of June 2008 2.1 million people aged 17 years and over had a registered diagnosis of diabetes.
- For the most recent 12 month period reported, October 2007 to September 2008, there were 31.9 million items prescribed at a net ingredient cost of £581.2 million.
- Between October 2007 and September 2008 the net ingredient cost of medicines for diabetes dispensed in hospitals was estimated to be far less than, only 2.1 per cent of, the net ingredient cost of medicines for diabetes dispensed in primary care.
Administrative Sources
NHS BSA, Quality and Outcomes Framework,ePACT, QOF, NDA
Resources
Last edited: 27 June 2018 9:22 am